Abstract
The effects of trimethylamine (TMA) on uptake mechanisms and lysosomal function were studied in mouse embryos, isolated yolk sacs and limb buds. TMA at 0.75 m m did not inhibit uptake of [ 14C]sucrose by yolk sacs of day 9 embryos or by day 15 isolated yolk sacs but did inhibit uptake of 125I-labelled bovine serum albumin ([ 125I]BSA) by day 15 isolated yolk sacs. Concentrations of TMA up to 2.5 m m did not inhibit lysosomal degradation of [ 125I]BSA by isolated yolk sacs, as judged by the release of trichloroacetic acid (TCA)-soluble radioactivity into the culture media. The inhibition of [ 125I]BSA uptake induced by TMA was reversible on removal of TMA. When day 8 embryos were cultured in serum containing [ 3H]leucine-labelled proteins, uptake and incorporation of radioactivity in 0.75 m m TMA-treated embryos was 47 and 44%, respectively, of that in untreated controls. TMA at 0.75 m m did not inhibit the uptake and incorporation of free [ 3H]leucine into embryonic protein nor the amount of free [ 3H]leucine taken up or incorporated into protein by day 12 isolated limb buds. It is concluded that the reduced macromolecular synthesis in embryos exposed to TMA is due to an inhibition of receptor-medicated uptake of nutrients by the yolk sac.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.